These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 9434317)

  • 21. First-pass effect of norethindrone in rabbits and rats.
    Back DJ; Breckenridge AM; Crawford FE; Orme ML; Rowe PH; Smith E
    J Pharmacol Exp Ther; 1978 Nov; 207(2):555-65. PubMed ID: 712638
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetics of ebrotidine in rats and dogs.
    Albet C; Pérez JA; Sacristán A; Ortiz JA
    Arzneimittelforschung; 1997 Apr; 47(4A):483-5. PubMed ID: 9205748
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stability, tissue metabolism, tissue distribution, and blood partition of DA-1131, a new carbapenem.
    Kim SH; Kim WB; Lee MG
    Res Commun Mol Pathol Pharmacol; 1995 Dec; 90(3):347-62. PubMed ID: 8746482
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dose-independent pharmacokinetics of a new reversible proton pump inhibitor, KR-60436, after intravenous and oral administration to rats: gastrointestinal first-pass effect.
    Yu SY; Bae SK; Kim EJ; Kim YG; Kim SO; Lee DH; Lim H; Lee MG
    J Pharm Sci; 2003 Aug; 92(8):1592-603. PubMed ID: 12884246
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Absorption, distribution, metabolism and excretion of telmesteine, a mucolitic agent, in rat.
    Lee J; Son J; Rhee SW; Kim DH
    Xenobiotica; 2003 Jul; 33(7):755-65. PubMed ID: 12893524
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetics of brucine after intravenous and oral administration to rats.
    Chen J; Xiao HL; Hu RR; Hu W; Chen ZP; Cai H; Liu X; Lu TL; Fang Y; Cai BC
    Fitoterapia; 2011 Dec; 82(8):1302-8. PubMed ID: 21958965
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetics of the antimalarial drug, AQ-13, in rats and cynomolgus macaques.
    Ramanathan-Girish S; Catz P; Creek MR; Wu B; Thomas D; Krogstad DJ; De D; Mirsalis JC; Green CE
    Int J Toxicol; 2004; 23(3):179-89. PubMed ID: 15204721
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetics and first-pass metabolism of astaxanthin in rats.
    Choi HD; Kang HE; Yang SH; Lee MG; Shin WG
    Br J Nutr; 2011 Jan; 105(2):220-7. PubMed ID: 20819240
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Determination of a new antiulcer agent, YJA-20379-1 in plasma, urine, blood, and tissue homogenates by high-performance liquid chromatography.
    Kim SH; Choi WS; Chang MS; Lee MG
    Res Commun Mol Pathol Pharmacol; 1997 Jul; 97(1):107-12. PubMed ID: 9507573
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hydroxypropyl-beta-cyclodextrin-flutamide inclusion complex. II. Oral and intravenous pharmacokinetics of flutamide in the rat.
    Zuo Z; Tam YK; Diakur J; Wiebe LI
    J Pharm Pharm Sci; 2002; 5(3):292-8. PubMed ID: 12553899
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dose-dependent pharmacokinetics and first-pass effects of mirodenafil, a new erectogenic, in rats.
    Choi YH; Lee YS; Bae SH; Kim TK; Lee BY; Lee MG
    Biopharm Drug Dispos; 2009 Sep; 30(6):305-17. PubMed ID: 19639551
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatic and intestinal first-pass effects of a new hepatoprotective agent, YH439, in rats.
    Kim J; Han KS; Lee JW; Lee MG
    Res Commun Mol Pathol Pharmacol; 1998 Nov; 102(2):125-36. PubMed ID: 10100504
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of enzyme inhibitor and absorption site following [D-ala2, D-leu5]enkephalin oral administration in rats.
    Lee HJ; Amidon GL
    Biopharm Drug Dispos; 2002 May; 23(4):131-41. PubMed ID: 12015787
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influence of cholestyramine on the pharmacokinetics of rosiglitazone and its metabolite, desmethylrosiglitazone, after oral and intravenous dosing of rosiglitazone: impact on oral bioavailability, absorption, and metabolic disposition in rats.
    Muzeeb S; Venkatesh P; Mullangi R; Srinivas NR
    Xenobiotica; 2006 Sep; 36(9):838-56. PubMed ID: 16971347
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetics and brain uptake of diazepam after intravenous and intranasal administration in rats and rabbits.
    Kaur P; Kim K
    Int J Pharm; 2008 Nov; 364(1):27-35. PubMed ID: 18760341
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetics, stability, and blood partition of 7-anilino-5,8-isoquinolinedione, a new isoquinonlinedione derivative.
    Kim SH; Moon YJ; Ryu CK; Lee MG
    Res Commun Mol Pathol Pharmacol; 2000; 107(5-6):419-29. PubMed ID: 11589368
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetics of lurasidone, a novel atypical anti-psychotic drug, in rats.
    Lee KR; Chae YJ; Koo TS
    Xenobiotica; 2011 Dec; 41(12):1100-7. PubMed ID: 21838595
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetics of oltipraz after intravenous and oral administration in rats with dehydration for 72 hours.
    Bae SK; Lee SJ; Kim JW; Kim YH; Kim SG; Lee MG
    Biopharm Drug Dispos; 2005 Mar; 26(2):77-83. PubMed ID: 15617135
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Species differences in pharmacokinetics of a hepatoprotective agent, YH439, and its metabolites, M4, M5, and M7, after intravenous and oral administration to rats, rabbits, and dogs.
    Yoon WH; Yoo JK; Lee JW; Shim CK; Lee MG
    Drug Metab Dispos; 1998 Feb; 26(2):152-63. PubMed ID: 9456302
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dose-linear pharmacokinetics of oleanolic acid after intravenous and oral administration in rats.
    Jeong DW; Kim YH; Kim HH; Ji HY; Yoo SD; Choi WR; Lee SM; Han CK; Lee HS
    Biopharm Drug Dispos; 2007 Mar; 28(2):51-7. PubMed ID: 17163409
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.